HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EM66 peptide

a 66-amino acid peptide from the proleoytic processsing of Secretogranin II; circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Chromogranins: 1100
      - Secretogranin II: 83
        EM66 peptide: 1
- Peptides: 82426
  - Peptide Fragments: 373
    - EM66 peptide: 1

Experts

1.	Anouar, Y: 1 article (04/2012)
2.	Guillemot, J: 1 article (04/2012)
3.	Guérin, M: 1 article (04/2012)
4.	Klein, M: 1 article (04/2012)
5.	Lefebvre, H: 1 article (04/2012)
6.	Montéro-Hadjadje, M: 1 article (04/2012)
7.	Muresan, M: 1 article (04/2012)
8.	Ravni, A: 1 article (04/2012)
9.	Seidah, N G: 1 article (04/2012)
10.	Thouënnon, E: 1 article (04/2012)

Related Diseases

1.	Pheochromocytoma 04/01/2012 - "EM66 peptide levels were 16-fold higher in benign than in malignant pheochromocytomas and had an area under the receiver-operating characteristic curve of 0.95 for the distinction of benign and malignant tumors. "
2.	Neoplasms (Cancer) 04/01/2012 - "EM66 peptide levels were 16-fold higher in benign than in malignant pheochromocytomas and had an area under the receiver-operating characteristic curve of 0.95 for the distinction of benign and malignant tumors. "